Literature DB >> 12691472

Etiology of Parkinson's disease.

Zhigao Huang1, Raúl de la Fuente-Fernández, A Jon Stoessl.   

Abstract

There is growing recognition that Parkinson's disease (PD) is likely to arise from the combined effects of genetic predisposition as well as largely unidentified environmental factors. The relative contribution of each varies from one individual to another. Even in situations where more than one family member is affected, the predominant influence may be environmental. Although responsible for only a small minority of cases of PD, recently identified genetic mutations have provided tremendous insights into the basis for neurodegeneration and have led to growing recognition of the importance of abnormal protein handling in Parkinson's as well as other neurodegenerative disorders. Abnormal protein handling may increase susceptibility to oxidative stress; conversely, numerous other factors, including oxidative stress and impaired mitochondrial function can lead to impaired protein degradation. A limited number of environmental factors are known to be toxic to the substantia nigra; in contrast, some factors such as caffeine intake and cigarette smoking may protect against the development of PD, although the mechanisms are not established. We review the various genetic and environmental factors thought to be involved in PD, as well as the mechanisms that contribute to selective nigral cell death.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12691472     DOI: 10.1017/s031716710000319x

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  7 in total

1.  Imbalanced estrogen metabolism in the brain: possible relevance to the etiology of Parkinson's disease.

Authors:  Nilesh W Gaikwad; Daniel Murman; Cheryl L Beseler; Muhammad Zahid; Eleanor G Rogan; Ercole L Cavalieri
Journal:  Biomarkers       Date:  2011-06-21       Impact factor: 2.658

2.  The parkin-like human homolog of Drosophila ariadne-1 (HHARI) can induce aggresome formation in mammalian cells and is immunologically detectable in Lewy bodies.

Authors:  Sangram S Parelkar; Juan G Cadena; Chul Kim; Zhaohui Wang; Rachel Sugal; Brooke Bentley; Luis Moral; Helen C Ardley; Lawrence M Schwartz
Journal:  J Mol Neurosci       Date:  2011-05-18       Impact factor: 3.444

3.  Ellagic Acid Protects the Brain Against 6-Hydroxydopamine Induced Neuroinflammation in a Rat Model of Parkinson's Disease.

Authors:  Yaghoob Farbood; Alireza Sarkaki; Mojtaba Dolatshahi; Seyed Mohammad Taqhi Mansouri; Ali Khodadadi
Journal:  Basic Clin Neurosci       Date:  2015-04

4.  Neuroprotective effects of linagliptin in a rotenone-induced rat model of Parkinson's disease.

Authors:  Kinjal V Abhangi; Jigneshkumar Ishwarlal Patel
Journal:  Indian J Pharmacol       Date:  2022 Jan-Feb       Impact factor: 1.200

Review 5.  Protective Mechanisms of Flavonoids in Parkinson's Disease.

Authors:  Kasthuri Bai Magalingam; Ammu Kutty Radhakrishnan; Nagaraja Haleagrahara
Journal:  Oxid Med Cell Longev       Date:  2015-10-20       Impact factor: 6.543

6.  Biocomplexity and Fractality in the Search of Biomarkers of Aging and Pathology: Mitochondrial DNA Profiling of Parkinson's Disease.

Authors:  Annamaria Zaia; Pierluigi Maponi; Martina Zannotti; Tiziana Casoli
Journal:  Int J Mol Sci       Date:  2020-03-04       Impact factor: 5.923

7.  Health-Related Quality of Life and Physical Function in Individuals with Parkinson's Disease after a Multidisciplinary Rehabilitation Regimen-A Prospective Cohort Feasibility Study.

Authors:  Christina Nielsen; Volkert Siersma; Emma Ghaziani; Nina Beyer; S Peter Magnusson; Christian Couppé
Journal:  Int J Environ Res Public Health       Date:  2020-10-21       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.